Consensus features of CP-MLR and GA in modeling HIV-1 RT inhibitory activity of 4-benzyl/benzoylpyridin-2-one analogues

References

• Pauwels R. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections. Curr Opin Pharmacol 2004;4:437–446.
   PubMed Web of Science ®Google Scholar
• Clercq ED. The design of drugs for HIV and HCV. Nat Rev Drug Discov 2007;6:1001–1018.
   PubMed Web of Science ®Google Scholar
• Safadi YE, Boudou VV, Marquet R. HIV-1 reverse transcriptase inhibitors. Appl Microbiol Biotechnol 2007;75:723–737.
   PubMed Web of Science ®Google Scholar
• Clercq ED. Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present and future. Chem Biodivers 2004;1:44–64.
   PubMedGoogle Scholar
• Prajapati DG, Ramajayam R, Yadav MR, Giridhar R. The search for potent, small molecule NNRTIs: A review. Bioorg Med Chem 2009;17:5744–5762.
   PubMed Web of Science ®Google Scholar
• Esnouf R, Ren J, Ross C, Jones Y, Stammers D, Stuart D. Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Nat Struct Biol 1995;2:303–308.
   PubMedGoogle Scholar
• Ragno R, Frasca S, Manetti F, Brizzi A, Massa S. HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies. J Med Chem 2005;48:200–212.
   PubMed Web of Science ®Google Scholar
• Clercq ED. Emerging antiHIV drugs. Expert Opin Emerg Drugs 2005;10: 241–274.
   PubMedGoogle Scholar
• Buckheit RW, Fliakas-Boltz V, Yeagy-Bargo S, Weislow O, Mayers DL, Boyer PL, Hughes SH, Pan BC, Chu SH, Bader JP. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase. Virology 1995;210:186–193.
   PubMed Web of Science ®Google Scholar
• Richman D, Shih CK, Lowy I, Rose J, Prodanovich P, Goff S, Griffin J. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci (USA) 1991;88:11241–11245.
   PubMed Web of Science ®Google Scholar
• Franco JLM, Mayorga KM, Gordiano CJ, Castillo R. Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors. Chem Med Chem 2007;2:1141–1147.
   Google Scholar
• Prabhakar YS, Solomon VR, Rawal RK, Gupta MK, Katti SB. CP-MLR/PLS Directed Structure–Activity Modeling of the HIV-1 RT Inhibitory Activity of 2,3-Diaryl-1,3-thiazolidin-4-ones. QSAR Comb Sci 2004;23:234–244.
   Google Scholar
• Prabhakar YS, Rawal RK, Gupta MK, Solomon VR, Katti SB. Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones. Comb Chem High T Scr 2005;5:431–437.
   Google Scholar
• Rawal RK, Prabhakar YS, Katti SB. Molecular surface features in modeling the HIV-1 RT inhibitory activity of 2-(2,6-disubstituted phenyl)-3-(substituted pyrimidin-2-yl)-thiazolidin-4-ones. QSAR Comb Sci 2007;26:398–406.
   Google Scholar
• Sharma BK, Kumar R, Singh P. Quantitative structure–activity relationship study of 2-arylsulfonyl-6-substituted benzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1. J Enzyme Inhib Med Chem 2002;17:219–225.
   PubMed Web of Science ®Google Scholar
• Benjahad A, Croisy M, Monneret C, Bisagni E, Mabire D, Coupa S et al. 4-Benzyl and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones: in vitro evaluation of new C-3-amino-substituted and C-5,6-alkyl-substituted analogues against clinically important HIV mutant strains. J Med Chem 2005;48:1948–1964.
   PubMed Web of Science ®Google Scholar
• DRAGON software version 5.0-2005. By Todeschini R, Consonni V, Mauri A, Pavan M. Milano, Italy. http://disat.unimib.it/chm/Dragon.htm.
   Google Scholar
• Reddy AS, Kumar S, Garg R. Hybrid-genetic algorithm based descriptor optimization and QSAR models for predicting the biological activity of Tipranavir analogs for HIV protease inhibition. J Mol Graph Model 2010;28:852–862.
   PubMed Web of Science ®Google Scholar
• Guha R, Stanton DT, Jurs PC. Interpreting computational neural network quantitative structure–activity relationship models: a detailed interpretation of the weights and biases. J Chem Inf Model 2005;45:1109–1121.
   PubMed Web of Science ®Google Scholar
• Prabhakar YS. A combinatorial approach to the variable selection in multiple linear regression analysis of Selwood et al. data set – a case study. QSAR Comb Sci 2003;22:583–595.
   Google Scholar
• Prabhakar YS, Gupta MK, Roy N, Venkateswarlu Y. A high dimensional QSAR study on the aldose reductase inhibitory activity of some flavones: topological descriptors in modeling the activity. J Chem Inf Model 2006;46:86–92.
   PubMed Web of Science ®Google Scholar
• Saquib M, Gupta MK, Sagar R, Prabhakar YS, Shaw AK, Kumar R, Maulik PR, Gaikwad AN, Sinha S, Srivastava AK, Chaturvedi V, Srivastava R, Srivastava BS. C-3 Alkyl/Arylalkyl-2,3-dideoxy Hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study. J Med Chem 2007;50:2942–2950.
   PubMed Web of Science ®Google Scholar
• Pavan M, Mauri A, Todeschini R. Total ranking models by the genetic algorithm variable subset selection (GA-VSS) approach for environmental priority settings. Anal Bioanal Chem 2004;380:430–444.
   PubMed Web of Science ®Google Scholar
• Deshpande S, Gupta MK, Prabhakar YS. Multi-model environment as a rational approach for drug design: an experience with CP-MLR. IUP J Chem 2010; 3:1–33.
   Google Scholar
• Rumelhart DE, Hinton GE, Williams RJ. Learning representations by backpropagating errors. Nature, 1986;323:533–536.
   Web of Science ®Google Scholar
• Gasteiger J, Zupan J. Neural networks in chemistry. Angew Chem Intl Ed Engl 1993;32:503–527.
   Web of Science ®Google Scholar
• Bishop CM. Neural Networks for Pattern Recognition. Clarendon Press: Oxford, 1995. P 116–163 and 253–294.
   Google Scholar
• Graupe D. Principles of Artificial Neural Networks, 2nd ed. World Scientific Publishing Co.: Singapore; 2007. P 59–111.
   Google Scholar
• ChemDraw Ultra 6.0 and Chem 3D Ultra, Cambridge Soft Corporation, Cambridge, USA.
   Google Scholar
• SYSTAT, Version 7.0: SPSS Inc., 444 North Michigan Avenue, Chicago, IL 60611.
   Google Scholar
• Wold S. Cross validatory estimation of the number of components in factor and principal components analysis. Technometrics 1978;20:397–406.
   Web of Science ®Google Scholar
• Stahle L, Wold S, in: Eillis GP, West WB. ggEds., Progress in Medicinal Chemistry, vol. 25, Elsevier Science Publishers, B.V. Amsterdam, 1988. P 291–338 (Chapter 6).
   Google Scholar
• So SS, Karplus M. Three-dimensional quantitative structure–activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations. J Med Chem 1997;40:4347–4359.
   PubMed Web of Science ®Google Scholar
• Todeschini R, Consonni V, Pavan M. MOBYDIGS software (Version 1.2) for Windows, Talete Srl, Milan, Italy, 2002. http://www.talete.mi.it/mobydigs.htm.
   Google Scholar
• Marini F, Bucci R, Magrì AL, Magrì AD. Artificial neural networks in chemometrics: History, examples and perspectives. Microchem J 2008;88:178–185.
   Web of Science ®Google Scholar
• Marquardt DW. An algorithm for leastsquares estimation of nonlinear parameters. J Soc Ind Appl Math 1963;11:431–441.
   Google Scholar
• Hagan MT, Menhaj MB. Training Feedforward Networks with the Marquardt Algorithm. IEEE T Neural Net 1994;5:989–993.
   PubMed Web of Science ®Google Scholar
• MATLAB, Version 7.6: <http://www.mathworks.com/products/matlab/>.
   Google Scholar
• Carlsson J, Boukharta L, Aqvist J. Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase. J Med Chem 2008;51:2648–2656.
   PubMed Web of Science ®Google Scholar
• Goodarzi M, Deshpande S, Murugesan V, Katti SB, Prabhakar YS. Is Feature Selection Essential for ANN Modeling? QSAR Comb Sci 2009; 28: 1487–1499.
   Google Scholar